| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 13 | +69.23% | -6.26% | -0.50% | -5.76% | -8.66% | — |
| 14d | 13 | +76.92% | -5.61% | -0.29% | -5.33% | -7.25% | — |
| 30d | 13 | +76.92% | -9.83% | -1.49% | -8.34% | -11.49% | — |
| 60d | 13 | +92.31% | -19.57% | -1.62% | -17.96% | -16.11% | — |
| 90d | 13 | +69.23% | -20.16% | -0.41% | -19.76% | -11.90% | — |
| 180d | 13 | +84.62% | -40.69% | -2.46% | -38.23% | -54.87% | — |
| 1y | 13 | +100.00% | -73.02% | -0.79% | -72.23% | -63.91% | — |
| 2y | 13 | +100.00% | -92.25% | +20.72% | -112.97% | -109.62% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PYXS PYXIS ONCOLOGY, INC. | SALE | 35,000 | — | — | 357,461 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| PYXS PYXIS ONCOLOGY, INC. | SALE10b5-1 10b5-1 plan | 35,000 | $3.06 | $107.1K | 38,741 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| PYXS PYXIS ONCOLOGY, INC. | PURCHASE | 35,000 | $1.60 | $56.0K | 73,741 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,000 | — | — | 5,000 | Jun 10, 2026 | Jun 11, 2026 ↗ | View → |
| PYXS PYXIS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 45,867 | — | — | 45,867 | Mar 24, 2026 | Mar 25, 2026 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 849 | — | — | 849 | Dec 12, 2025 | Dec 16, 2025 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | SALE | 849 | — | — | 0 | Dec 12, 2025 | Dec 16, 2025 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,000 | — | — | 1,000 | Dec 12, 2025 | Dec 16, 2025 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | SALE | 1,000 | — | — | 0 | Dec 12, 2025 | Dec 16, 2025 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | SALE | 1,100 | — | — | 0 | Dec 12, 2025 | Dec 16, 2025 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | SALE | 2,500 | — | — | 0 | Dec 12, 2025 | Dec 16, 2025 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 2,500 | — | — | 2,500 | Dec 12, 2025 | Dec 16, 2025 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,100 | — | — | 1,100 | Dec 12, 2025 | Dec 16, 2025 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,100 | — | — | 1,100 | May 27, 2025 | Jul 2, 2025 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | May 1, 2025 | May 1, 2025 ↗ | View → |
| PYXS PYXIS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 36,979 | $0.98 | $36.2K | 36,979 | Mar 31, 2025 | Apr 2, 2025 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 16,984 | — | — | 16,984 | Sep 3, 2024 | Sep 6, 2024 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Sep 3, 2024 | Sep 6, 2024 ↗ | View → |
| PYXS PYXIS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 38,741 | — | — | 38,741 | Mar 26, 2024 | Mar 28, 2024 ↗ | View → |
| PYXS PYXIS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 392,461 | — | — | 392,461 | Sep 22, 2023 | Sep 26, 2023 ↗ | View → |
| PYXS PYXIS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 3,534 | — | — | 3,534 | Aug 23, 2023 | Aug 25, 2023 ↗ | View → |
| PYXS PYXIS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 5,879 | — | — | 5,879 | Aug 23, 2023 | Aug 25, 2023 ↗ | View → |
| PYXS PYXIS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 17,250 | — | — | 17,250 | Aug 23, 2023 | Aug 25, 2023 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 5,074 | $3.63 | $18.4K | 290,794 | Mar 2, 2023 | Mar 6, 2023 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 141,328 | — | — | 295,868 | Mar 1, 2023 | Mar 3, 2023 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 317,987 | — | — | 317,987 | Mar 1, 2023 | Mar 3, 2023 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 3,218 | $4.49 | $14.4K | 155,664 | Nov 16, 2022 | Nov 18, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 1,124 | $4.49 | $5.0K | 154,540 | Nov 16, 2022 | Nov 18, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 4,124 | $5.03 | $20.8K | 158,882 | Aug 16, 2022 | Aug 18, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 3,873 | $5.32 | $20.6K | 163,006 | May 17, 2022 | May 19, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 78,506 | — | — | 169,100 | Mar 1, 2022 | Mar 3, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 147,573 | — | — | 147,573 | Mar 1, 2022 | Mar 3, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 2,221 | $9.86 | $21.9K | 166,879 | Mar 1, 2022 | Mar 3, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 5,000 | $16.00 | $80.0K | 90,594 | Feb 10, 2022 | Feb 14, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | PURCHASE EVP, Head of R&D | 5,000 | $9.58 | $47.9K | 95,594 | Feb 10, 2022 | Feb 14, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 5,000 | — | — | 257,500 | Feb 10, 2022 | Feb 14, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 5,000 | $16.01 | $80.0K | 90,594 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 5,000 | — | — | 262,500 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | PURCHASE EVP, Head of R&D | 5,000 | $9.58 | $47.9K | 95,594 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 5,000 | $17.94 | $89.7K | 90,594 | Dec 1, 2021 | Dec 3, 2021 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | PURCHASE EVP, Head of R&D | 5,000 | $9.58 | $47.9K | 95,594 | Dec 1, 2021 | Dec 3, 2021 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 5,000 | — | — | 267,500 | Dec 1, 2021 | Dec 3, 2021 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 2,199 | $17.12 | $37.6K | 90,594 | Nov 16, 2021 | Nov 18, 2021 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 5,000 | $16.41 | $82.0K | 92,793 | Nov 2, 2021 | Nov 4, 2021 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 5,000 | — | — | 272,500 | Nov 2, 2021 | Nov 4, 2021 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | PURCHASE EVP, Head of R&D | 5,000 | $9.58 | $47.9K | 97,793 | Nov 2, 2021 | Nov 4, 2021 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 2,152 | $12.53 | $27.0K | 92,793 | Aug 17, 2021 | Aug 19, 2021 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | SALE EVP, Head of R&D | 5,184 | $14.55 | $75.4K | 94,945 | May 18, 2021 | May 20, 2021 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 53,879 | — | — | 100,129 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 81,327 | — | — | 81,327 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 46,250 | — | — | 46,250 | May 14, 2020 | May 19, 2020 ↗ | View → |
| ATRA ATARA BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 277,500 | — | — | 277,500 | May 14, 2020 | May 19, 2020 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 71,500 | — | — | 71,500 | Feb 14, 2020 | Feb 19, 2020 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 46,500 | — | — | 46,500 | Feb 14, 2020 | Feb 19, 2020 ↗ | View → |